louisiana semaglutide intestinal paralysis class action stomach The GLP-1 RA Legal Timeline: How Serious Side Effects Led to Multidistrict Litigation semaglutide ileus class action in

The American Journal of Clinical Nutrition, Volume 122, Issue 1, 344 - 367

J Am Coll Nutr 1999;18:77-82

GLP-1 single and dual agonists Product Specifications Quality & Testing Retatrutide is independently tested by an ISO 17025-accredited laboratory using HPLC and mass spectrometry to confirm identity and verify purity at 99%

Pipeline Other than Novo Nordisk and Eli Lilly, only Amgen6 and Viking Therapeutics have a weight loss drug that is in phase 3 trials

Obesity is a chronic condition, and patients may benefit from taking GLP-1s long term, especially if they also have conditions such as diabetes, cardiovascular disease, obstructive sleep apnea, or metabolic dysfunction-associated steatohepatitis (MASH)